Patents

US 8664189 B2: RNA interference in skin indications

Granted
2014-03-04
Filed
2009-09-22 application 13120315
Type
Utility · 2 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The present invention relates to RNAi constructs with improved tissue and cellular uptake characteristics and methods of use of these compounds in dermal applications.

Source: PVGPATDIS, file of 2026-04-10 (ipg140304.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
RXi Pharmaceuticals Corporation 17 patentsUS company or organizationWestborough, MAPVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Anastasia KhvorovaWestborough, MA193PVGPATDIS, file of 2026-04-10
William SalomonWorcester, MA35PVGPATDIS, file of 2026-04-10
Joanne KamensNewton, MA30PVGPATDIS, file of 2026-04-10
Dmitry SamarskyWestborough, MA30PVGPATDIS, file of 2026-04-10
Tod M. WoolfSudbury, MA41PVGPATDIS, file of 2026-04-10
Pamela PavcoLongmont, CO14PVGPATDIS, file of 2026-04-10
James CardiaFranklin, MA23PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N15/1136PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P1/16PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2018-12-07Name change
Change of name
RXI PHARMACEUTICALS CORPORATION signed 2018-11-14PHIO PHARMACEUTICALS CORP. MARLBOROUGH, MA48380/9PASDL, file of 2026-10-15
2013-07-12Assignment
Assignment of assignor's interest
WOOLF, TOD M. signed 2012-07-31
KAMENS, JOANNE signed 2012-08-06
KHVOROVA, ANASTASIA signed 2012-08-07
SALOMON, WILLIAM signed 2012-08-07
PAVCO, PAMELA A. signed 2012-08-30
SAMARSKY, DMITRY signed 2012-09-04
CARDIA, JAMES signed 2013-06-26
RXI PHARMACEUTICALS CORPORATION WORCESTER, MA30786/777ECORSEXC, file of 2026-09-25
2012-05-02Release of security interest
Release of security interest
TANG CAPITAL PARTNERS, LP signed 2012-05-01RXI PHARMACEUTICALS CORPORATION WORCESTER, MA28144/110PASDL, file of 2026-10-15
2011-09-29Name change
Change of name
RNCS, INC. signed 2011-09-26RXI PHARMACEUTICALS CORPORATION WORCESTER, MA26988/874PASDL, file of 2026-10-15
2011-09-26Security interest Security interest
Security agreement
RNCS, INC. signed 2011-09-24TANG CAPITAL PARTNERS, LP SAN DIEGO, CA26976/187PASDL, file of 2026-10-15
2011-09-26Assignment
Assignment of assignor's interest
RXI PHARMACEUTICALS CORPORATION signed 2011-09-24RNCS, INC. WORCESTER, MA26969/660PASDL, file of 2026-10-15

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.